Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
LIDDS: Updated Research Report from Redeye | ||
By: Nasdaq / GlobeNewswire - 23 Apr 2019 | Back to overview list |
|
Redeye has today released an updated research report on LIDDS covering its expanded portfolio that now also includes a project targeting Toll-like Receptors (TLR). The updated research report examines the development of Toll-like Receptors and the current market looking specifically at TLR9, the focus for LIDDS TLR research. The report also includes an update on Phase IIB Liproca Depot Study. The updated research report is available at: https://www.redeye.se/company/lidds Monica Wallter, CEO, will present LIDDS at the Redeye Investor After Work in Gothenburg on 25 April 2019. For more information, please contact: Attachment |
||
|
||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |